Piotr Zimniak
Concepts (603)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glutathione Transferase | 62 | 2016 | 174 | 5.790 |
Why?
| Aldehydes | 35 | 2015 | 83 | 4.020 |
Why?
| Longevity | 7 | 2012 | 80 | 1.680 |
Why?
| Lipid Peroxidation | 14 | 2016 | 100 | 1.640 |
Why?
| Isoenzymes | 26 | 2009 | 168 | 1.350 |
Why?
| Caenorhabditis elegans | 6 | 2011 | 138 | 1.220 |
Why?
| Carrier Proteins | 22 | 2004 | 304 | 1.150 |
Why?
| Oxidative Stress | 16 | 2011 | 770 | 1.030 |
Why?
| Glutathione | 33 | 2009 | 295 | 0.990 |
Why?
| Bile Acids and Salts | 20 | 2002 | 75 | 0.970 |
Why?
| Adenosine Triphosphatases | 22 | 2003 | 87 | 0.870 |
Why?
| Caenorhabditis elegans Proteins | 4 | 2011 | 56 | 0.810 |
Why?
| Animals | 85 | 2016 | 13187 | 0.770 |
Why?
| Lithocholic Acid | 12 | 2003 | 20 | 0.760 |
Why?
| ATP-Binding Cassette Transporters | 14 | 2003 | 34 | 0.710 |
Why?
| Adenosine Triphosphate | 19 | 2003 | 233 | 0.640 |
Why?
| GTPase-Activating Proteins | 12 | 2003 | 23 | 0.620 |
Why?
| Receptors, Muscarinic | 5 | 2003 | 19 | 0.600 |
Why?
| Xenobiotics | 6 | 2003 | 30 | 0.600 |
Why?
| Liver | 20 | 2016 | 1115 | 0.590 |
Why?
| Aging | 4 | 2011 | 687 | 0.580 |
Why?
| Signal Transduction | 13 | 2011 | 1618 | 0.470 |
Why?
| Fatty Acids | 3 | 2011 | 146 | 0.450 |
Why?
| Microsomes, Liver | 12 | 1992 | 186 | 0.430 |
Why?
| Mice | 32 | 2016 | 5739 | 0.420 |
Why?
| Geriatrics | 1 | 2012 | 46 | 0.400 |
Why?
| Cloning, Molecular | 7 | 2009 | 185 | 0.380 |
Why?
| Doxorubicin | 12 | 2003 | 233 | 0.380 |
Why?
| Obesity | 2 | 2010 | 1113 | 0.370 |
Why?
| Kinetics | 35 | 2004 | 623 | 0.370 |
Why?
| Cell Membrane | 16 | 2009 | 248 | 0.360 |
Why?
| Substrate Specificity | 22 | 2004 | 194 | 0.340 |
Why?
| Adipose Tissue | 2 | 2008 | 187 | 0.340 |
Why?
| DNA | 4 | 2009 | 541 | 0.340 |
Why?
| Muscarinic Antagonists | 4 | 2003 | 21 | 0.340 |
Why?
| Molecular Sequence Data | 14 | 2009 | 792 | 0.320 |
Why?
| Colonic Neoplasms | 4 | 2005 | 161 | 0.320 |
Why?
| Metabolic Detoxication, Phase I | 1 | 2008 | 11 | 0.310 |
Why?
| Apoptosis | 11 | 2008 | 1101 | 0.310 |
Why?
| Enzyme Inhibitors | 1 | 2010 | 391 | 0.310 |
Why?
| Gene Expression | 4 | 2009 | 609 | 0.310 |
Why?
| Lipid Metabolism | 1 | 2008 | 175 | 0.300 |
Why?
| Catalysis | 12 | 2009 | 88 | 0.280 |
Why?
| Rats | 31 | 2005 | 3305 | 0.280 |
Why?
| Calcium | 8 | 1991 | 396 | 0.280 |
Why?
| Growth Inhibitors | 2 | 2005 | 27 | 0.270 |
Why?
| Chief Cells, Gastric | 2 | 2003 | 2 | 0.270 |
Why?
| Drosophila melanogaster | 2 | 2003 | 30 | 0.270 |
Why?
| Alleles | 9 | 2004 | 250 | 0.270 |
Why?
| Anions | 3 | 1994 | 7 | 0.270 |
Why?
| Receptor, Insulin | 1 | 2005 | 41 | 0.260 |
Why?
| Base Sequence | 9 | 2011 | 643 | 0.260 |
Why?
| Glucuronates | 12 | 1992 | 23 | 0.260 |
Why?
| Mitogen-Activated Protein Kinases | 8 | 2004 | 155 | 0.260 |
Why?
| Transfection | 11 | 2009 | 354 | 0.250 |
Why?
| Liver Diseases, Alcoholic | 2 | 2015 | 35 | 0.250 |
Why?
| Leukemia L5178 | 1 | 2005 | 2 | 0.250 |
Why?
| Citric Acid | 3 | 2010 | 16 | 0.250 |
Why?
| Thymidine Kinase | 1 | 2005 | 19 | 0.250 |
Why?
| Erythrocytes | 5 | 2003 | 83 | 0.250 |
Why?
| Mutagens | 1 | 2005 | 51 | 0.250 |
Why?
| Humans | 74 | 2012 | 49974 | 0.250 |
Why?
| Blotting, Western | 15 | 2016 | 601 | 0.250 |
Why?
| Gene Expression Regulation, Enzymologic | 3 | 2009 | 181 | 0.240 |
Why?
| Biological Transport | 15 | 2003 | 174 | 0.240 |
Why?
| Carcinogens | 7 | 2002 | 199 | 0.240 |
Why?
| Amino Acid Sequence | 12 | 2009 | 585 | 0.240 |
Why?
| Recombinant Proteins | 11 | 2009 | 486 | 0.240 |
Why?
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 5 | 2004 | 10 | 0.230 |
Why?
| RNA Interference | 4 | 2011 | 179 | 0.230 |
Why?
| Models, Molecular | 9 | 2004 | 338 | 0.230 |
Why?
| Phospholipids | 8 | 2001 | 57 | 0.230 |
Why?
| Biological Transport, Active | 15 | 2002 | 30 | 0.220 |
Why?
| Mutagenesis, Site-Directed | 8 | 2004 | 99 | 0.220 |
Why?
| Molecular Mimicry | 1 | 2002 | 38 | 0.210 |
Why?
| Binding Sites | 10 | 2004 | 374 | 0.210 |
Why?
| Membrane Glycoproteins | 5 | 1994 | 240 | 0.210 |
Why?
| Taurine | 3 | 2002 | 15 | 0.210 |
Why?
| Water | 2 | 1999 | 77 | 0.200 |
Why?
| Chromatography, Affinity | 8 | 2009 | 38 | 0.190 |
Why?
| Drug Resistance, Neoplasm | 5 | 2003 | 308 | 0.190 |
Why?
| K562 Cells | 9 | 2009 | 42 | 0.190 |
Why?
| Cell Line | 8 | 2009 | 1000 | 0.170 |
Why?
| Aconitate Hydratase | 2 | 2010 | 9 | 0.170 |
Why?
| Acetyl-CoA Carboxylase | 2 | 2010 | 13 | 0.170 |
Why?
| Carcinoembryonic Antigen | 1 | 1999 | 14 | 0.170 |
Why?
| Valine | 3 | 2000 | 58 | 0.170 |
Why?
| Taurolithocholic Acid | 5 | 2002 | 7 | 0.170 |
Why?
| Azotobacter | 4 | 1983 | 4 | 0.170 |
Why?
| Lipid Peroxides | 4 | 2008 | 10 | 0.160 |
Why?
| Phosphorylation | 7 | 2009 | 535 | 0.160 |
Why?
| Reactive Oxygen Species | 3 | 2011 | 408 | 0.160 |
Why?
| Cysteine Proteinase Inhibitors | 4 | 2009 | 22 | 0.160 |
Why?
| Malonyl Coenzyme A | 2 | 2008 | 7 | 0.160 |
Why?
| CHO Cells | 6 | 2003 | 120 | 0.160 |
Why?
| Cricetinae | 6 | 2003 | 192 | 0.160 |
Why?
| PPAR alpha | 2 | 2016 | 58 | 0.160 |
Why?
| Escherichia coli | 5 | 2009 | 186 | 0.150 |
Why?
| Acetylcholine | 5 | 2003 | 54 | 0.150 |
Why?
| Structure-Activity Relationship | 7 | 2004 | 395 | 0.150 |
Why?
| Isoleucine | 3 | 2004 | 27 | 0.150 |
Why?
| Proteolipids | 7 | 2003 | 10 | 0.140 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 595 | 0.140 |
Why?
| Bile | 4 | 1990 | 24 | 0.140 |
Why?
| Mice, Knockout | 6 | 2016 | 841 | 0.140 |
Why?
| Hyperbilirubinemia, Hereditary | 2 | 1993 | 2 | 0.140 |
Why?
| Hyperbilirubinemia | 2 | 1993 | 9 | 0.130 |
Why?
| Animals, Genetically Modified | 2 | 2005 | 49 | 0.130 |
Why?
| Lung | 3 | 1996 | 486 | 0.130 |
Why?
| Cholestasis | 2 | 1998 | 40 | 0.130 |
Why?
| Mitochondrial Proteins | 1 | 2015 | 90 | 0.130 |
Why?
| Rats, Inbred Strains | 12 | 1992 | 196 | 0.120 |
Why?
| Male | 27 | 2014 | 25241 | 0.120 |
Why?
| Antibiotics, Antineoplastic | 3 | 2003 | 78 | 0.120 |
Why?
| Chrysenes | 3 | 1998 | 3 | 0.120 |
Why?
| Carcinoma, Hepatocellular | 1 | 1997 | 191 | 0.120 |
Why?
| Mutation | 4 | 2009 | 1294 | 0.120 |
Why?
| Genes | 1 | 1994 | 33 | 0.120 |
Why?
| Sodium | 2 | 1993 | 92 | 0.120 |
Why?
| Organic Anion Transporters, Sodium-Dependent | 1 | 1993 | 3 | 0.120 |
Why?
| Hydroxysteroid Dehydrogenases | 1 | 1993 | 4 | 0.120 |
Why?
| Protein Processing, Post-Translational | 3 | 2015 | 171 | 0.120 |
Why?
| Erythrocyte Membrane | 4 | 2001 | 14 | 0.120 |
Why?
| Symporters | 1 | 1993 | 17 | 0.110 |
Why?
| Jaundice, Chronic Idiopathic | 1 | 1993 | 1 | 0.110 |
Why?
| Crystallography, X-Ray | 5 | 2004 | 147 | 0.110 |
Why?
| RNA, Messenger | 5 | 2014 | 1105 | 0.110 |
Why?
| Lung Neoplasms | 4 | 2003 | 606 | 0.110 |
Why?
| Hot Temperature | 3 | 2001 | 207 | 0.110 |
Why?
| Ionophores | 2 | 1991 | 6 | 0.110 |
Why?
| Mice, Inbred C57BL | 2 | 2009 | 1816 | 0.110 |
Why?
| Polymerase Chain Reaction | 2 | 2016 | 453 | 0.110 |
Why?
| Glutathione S-Transferase pi | 7 | 2002 | 24 | 0.110 |
Why?
| Electrophoresis, Polyacrylamide Gel | 6 | 2002 | 102 | 0.110 |
Why?
| Liver Neoplasms | 1 | 1997 | 326 | 0.110 |
Why?
| Steroids | 2 | 2004 | 57 | 0.110 |
Why?
| Sequence Homology, Amino Acid | 4 | 2009 | 144 | 0.110 |
Why?
| Liposomes | 6 | 2003 | 48 | 0.100 |
Why?
| Glucagon | 2 | 1983 | 22 | 0.100 |
Why?
| Oxidation-Reduction | 3 | 2008 | 322 | 0.100 |
Why?
| Internationality | 1 | 2012 | 36 | 0.100 |
Why?
| Carcinogens, Environmental | 2 | 2004 | 22 | 0.100 |
Why?
| Electrophoresis | 2 | 2009 | 16 | 0.100 |
Why?
| Calcium-Binding Proteins | 2 | 1983 | 54 | 0.100 |
Why?
| Epinephrine | 2 | 1983 | 96 | 0.100 |
Why?
| Wound Infection | 1 | 2011 | 27 | 0.100 |
Why?
| Sarcoplasmic Reticulum | 5 | 1991 | 21 | 0.100 |
Why?
| Cholic Acids | 2 | 1990 | 2 | 0.100 |
Why?
| Antineoplastic Agents | 4 | 2003 | 1171 | 0.100 |
Why?
| Peptide Fragments | 6 | 2009 | 215 | 0.100 |
Why?
| Stereoisomerism | 6 | 2004 | 104 | 0.100 |
Why?
| Dinitrochlorobenzene | 3 | 2001 | 5 | 0.090 |
Why?
| Inositol Phosphates | 4 | 2002 | 13 | 0.090 |
Why?
| Radioligand Assay | 4 | 2002 | 46 | 0.090 |
Why?
| Bacterial Infections | 1 | 2011 | 95 | 0.090 |
Why?
| Amiloride | 1 | 1990 | 8 | 0.090 |
Why?
| Bicarbonates | 1 | 1990 | 17 | 0.090 |
Why?
| Lipids | 1 | 2011 | 147 | 0.090 |
Why?
| Phenanthrenes | 2 | 2000 | 12 | 0.090 |
Why?
| Anion Transport Proteins | 3 | 1994 | 4 | 0.090 |
Why?
| Bacterial Proteins | 2 | 2004 | 376 | 0.090 |
Why?
| Tumor Cells, Cultured | 6 | 2003 | 465 | 0.090 |
Why?
| Polycyclic Compounds | 2 | 2001 | 6 | 0.090 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 1991 | 195 | 0.090 |
Why?
| JNK Mitogen-Activated Protein Kinases | 6 | 2007 | 72 | 0.090 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 2009 | 48 | 0.090 |
Why?
| Adaptor Proteins, Signal Transducing | 2 | 2007 | 197 | 0.090 |
Why?
| Burns | 1 | 2011 | 162 | 0.090 |
Why?
| Mixed Function Oxygenases | 1 | 1989 | 25 | 0.080 |
Why?
| Cell Division | 5 | 2004 | 292 | 0.080 |
Why?
| Vimentin | 1 | 2009 | 32 | 0.080 |
Why?
| Disease Models, Animal | 4 | 2016 | 1455 | 0.080 |
Why?
| Glucuronosyltransferase | 6 | 1991 | 126 | 0.080 |
Why?
| Aldehyde Dehydrogenase | 1 | 2008 | 26 | 0.080 |
Why?
| Amino Acid Substitution | 4 | 2004 | 82 | 0.080 |
Why?
| Receptor, Muscarinic M3 | 3 | 2002 | 7 | 0.080 |
Why?
| Serotonin Plasma Membrane Transport Proteins | 1 | 2009 | 47 | 0.080 |
Why?
| Retinal Pigment Epithelium | 1 | 2008 | 18 | 0.080 |
Why?
| Recombinant Fusion Proteins | 3 | 2005 | 181 | 0.080 |
Why?
| Female | 15 | 2016 | 26472 | 0.080 |
Why?
| Genotype | 1 | 2009 | 537 | 0.080 |
Why?
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2007 | 2 | 0.080 |
Why?
| Antigens, Differentiation, Myelomonocytic | 1 | 2008 | 39 | 0.080 |
Why?
| Fas Ligand Protein | 1 | 2007 | 17 | 0.080 |
Why?
| Glucose Tolerance Test | 1 | 2008 | 57 | 0.080 |
Why?
| Deoxycholic Acid | 3 | 2002 | 17 | 0.080 |
Why?
| Catalase | 3 | 1976 | 67 | 0.080 |
Why?
| Serotonin | 1 | 2009 | 152 | 0.080 |
Why?
| Homeostasis | 2 | 2008 | 200 | 0.080 |
Why?
| Models, Animal | 2 | 2005 | 233 | 0.080 |
Why?
| Dose-Response Relationship, Drug | 7 | 2007 | 1376 | 0.070 |
Why?
| Enzyme Stability | 2 | 1999 | 20 | 0.070 |
Why?
| Cells, Cultured | 7 | 2009 | 1573 | 0.070 |
Why?
| Gene Library | 2 | 2004 | 43 | 0.070 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2008 | 202 | 0.070 |
Why?
| Cell Nucleus | 1 | 2007 | 183 | 0.070 |
Why?
| Cholinergic Agonists | 2 | 2003 | 10 | 0.070 |
Why?
| Polymorphism, Genetic | 5 | 2000 | 181 | 0.070 |
Why?
| Cell Line, Transformed | 2 | 2004 | 72 | 0.070 |
Why?
| Chromatography, High Pressure Liquid | 7 | 1998 | 349 | 0.070 |
Why?
| Saccharomyces cerevisiae | 3 | 1976 | 190 | 0.070 |
Why?
| Carcinoma, Non-Small-Cell Lung | 3 | 2003 | 154 | 0.070 |
Why?
| Antigens, CD | 1 | 2008 | 219 | 0.070 |
Why?
| Molecular Weight | 4 | 1995 | 84 | 0.070 |
Why?
| Protein Kinase C | 3 | 1998 | 71 | 0.070 |
Why?
| Hydroxylation | 4 | 1991 | 61 | 0.070 |
Why?
| Neoplasm Proteins | 2 | 2003 | 322 | 0.070 |
Why?
| Genetic Vectors | 2 | 2004 | 125 | 0.070 |
Why?
| Promoter Regions, Genetic | 2 | 2005 | 475 | 0.070 |
Why?
| Alanine | 3 | 2004 | 42 | 0.070 |
Why?
| Protein Isoforms | 4 | 2015 | 119 | 0.070 |
Why?
| Nuclear Proteins | 1 | 2007 | 242 | 0.070 |
Why?
| Muscle, Skeletal | 1 | 2011 | 750 | 0.070 |
Why?
| Guinea Pigs | 2 | 2003 | 74 | 0.070 |
Why?
| Carbon Tetrachloride | 1 | 2005 | 22 | 0.070 |
Why?
| Insulin Resistance | 1 | 2008 | 264 | 0.070 |
Why?
| Receptors, Steroid | 1 | 2005 | 19 | 0.070 |
Why?
| Epithelium, Corneal | 1 | 2005 | 9 | 0.070 |
Why?
| Transcription Factors | 2 | 2007 | 561 | 0.070 |
Why?
| N-Methylscopolamine | 2 | 2002 | 3 | 0.060 |
Why?
| DNA Primers | 3 | 2011 | 207 | 0.060 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 64 | 0.060 |
Why?
| Multidrug Resistance-Associated Proteins | 3 | 2001 | 17 | 0.060 |
Why?
| Magnetic Resonance Spectroscopy | 8 | 1992 | 244 | 0.060 |
Why?
| Blood Glucose | 1 | 2008 | 439 | 0.060 |
Why?
| Protein Conformation | 3 | 2002 | 166 | 0.060 |
Why?
| Steroid Isomerases | 1 | 2004 | 1 | 0.060 |
Why?
| Hydrogen-Ion Concentration | 4 | 1996 | 175 | 0.060 |
Why?
| Forkhead Transcription Factors | 1 | 2005 | 112 | 0.060 |
Why?
| Models, Biological | 4 | 2008 | 727 | 0.060 |
Why?
| Stress, Psychological | 1 | 2006 | 260 | 0.060 |
Why?
| Peptide Mapping | 5 | 1996 | 22 | 0.060 |
Why?
| DNA, Complementary | 2 | 2002 | 135 | 0.060 |
Why?
| Phosphatidylcholines | 2 | 2001 | 25 | 0.060 |
Why?
| Insulin | 2 | 2005 | 457 | 0.060 |
Why?
| Subcellular Fractions | 2 | 2001 | 34 | 0.060 |
Why?
| Cell Transformation, Neoplastic | 1 | 2005 | 177 | 0.060 |
Why?
| Rats, Mutant Strains | 3 | 1993 | 9 | 0.060 |
Why?
| Oxidants | 2 | 2011 | 53 | 0.060 |
Why?
| Lactones | 1 | 2004 | 26 | 0.060 |
Why?
| Islets of Langerhans | 1 | 2004 | 24 | 0.060 |
Why?
| Microsomes | 2 | 1983 | 35 | 0.060 |
Why?
| Blotting, Southern | 1 | 2004 | 42 | 0.060 |
Why?
| Gene Deletion | 2 | 2015 | 266 | 0.060 |
Why?
| Arteriosclerosis | 1 | 2004 | 54 | 0.060 |
Why?
| Malondialdehyde | 1 | 2004 | 51 | 0.060 |
Why?
| Gene Expression Regulation | 2 | 2006 | 976 | 0.060 |
Why?
| Egtazic Acid | 1 | 2003 | 16 | 0.060 |
Why?
| Vinca Alkaloids | 1 | 2003 | 1 | 0.060 |
Why?
| Calcium-Transporting ATPases | 4 | 1991 | 14 | 0.060 |
Why?
| Hydrogen Peroxide | 2 | 2011 | 115 | 0.060 |
Why?
| Plasmids | 1 | 2004 | 161 | 0.060 |
Why?
| GTP-Binding Proteins | 1 | 2003 | 90 | 0.060 |
Why?
| Epoxy Compounds | 2 | 2000 | 45 | 0.060 |
Why?
| Mice, Inbred BALB C | 1 | 2004 | 304 | 0.060 |
Why?
| Tetrazolium Salts | 2 | 2003 | 13 | 0.050 |
Why?
| Multigene Family | 1 | 2003 | 56 | 0.050 |
Why?
| Drosophila Proteins | 1 | 2003 | 25 | 0.050 |
Why?
| Protein-Tyrosine Kinases | 1 | 2003 | 95 | 0.050 |
Why?
| Thiotepa | 2 | 2000 | 5 | 0.050 |
Why?
| Conserved Sequence | 1 | 2003 | 56 | 0.050 |
Why?
| Allyl Compounds | 1 | 2002 | 10 | 0.050 |
Why?
| Garlic | 1 | 2002 | 5 | 0.050 |
Why?
| Crystallization | 2 | 1999 | 32 | 0.050 |
Why?
| Disulfides | 1 | 2002 | 17 | 0.050 |
Why?
| Acetylcholinesterase | 1 | 2002 | 19 | 0.050 |
Why?
| Arginine | 2 | 2001 | 179 | 0.050 |
Why?
| Thiazoles | 2 | 2003 | 52 | 0.050 |
Why?
| Down-Regulation | 3 | 2011 | 348 | 0.050 |
Why?
| Anticarcinogenic Agents | 1 | 2002 | 34 | 0.050 |
Why?
| Colchicine | 2 | 2001 | 28 | 0.050 |
Why?
| Muscle, Smooth | 1 | 2002 | 63 | 0.050 |
Why?
| Antineoplastic Agents, Alkylating | 2 | 2000 | 74 | 0.050 |
Why?
| Binding, Competitive | 3 | 1998 | 94 | 0.050 |
Why?
| Phytotherapy | 1 | 2002 | 44 | 0.050 |
Why?
| Immunoglobulin G | 4 | 2003 | 186 | 0.050 |
Why?
| Phylogeny | 1 | 2003 | 235 | 0.050 |
Why?
| Chromatography, Thin Layer | 5 | 2002 | 24 | 0.050 |
Why?
| Survival Analysis | 1 | 2004 | 653 | 0.050 |
Why?
| Aorta, Thoracic | 1 | 2002 | 92 | 0.050 |
Why?
| Carcinoma, Small Cell | 4 | 2003 | 25 | 0.050 |
Why?
| Protein Binding | 2 | 2001 | 660 | 0.050 |
Why?
| Bone Density | 1 | 2004 | 379 | 0.050 |
Why?
| Body Composition | 1 | 2004 | 318 | 0.050 |
Why?
| Coronary Artery Disease | 1 | 2005 | 274 | 0.050 |
Why?
| Indicators and Reagents | 1 | 2001 | 36 | 0.050 |
Why?
| Quaternary Ammonium Compounds | 1 | 1981 | 29 | 0.050 |
Why?
| Methyltransferases | 1 | 1981 | 27 | 0.050 |
Why?
| Leucine | 2 | 1999 | 116 | 0.050 |
Why?
| Chlorambucil | 1 | 2000 | 4 | 0.050 |
Why?
| Phenotype | 1 | 2004 | 729 | 0.050 |
Why?
| Antiporters | 1 | 1980 | 19 | 0.050 |
Why?
| Cation Transport Proteins | 1 | 1980 | 27 | 0.050 |
Why?
| Hepatocytes | 1 | 2001 | 182 | 0.050 |
Why?
| Antioxidants | 1 | 2002 | 249 | 0.050 |
Why?
| Time Factors | 5 | 2003 | 2903 | 0.040 |
Why?
| Alkanesulfonic Acids | 1 | 1999 | 3 | 0.040 |
Why?
| Enzyme Precursors | 2 | 1976 | 5 | 0.040 |
Why?
| Tissue Distribution | 2 | 2002 | 163 | 0.040 |
Why?
| Valinomycin | 2 | 1994 | 2 | 0.040 |
Why?
| Morpholines | 1 | 1999 | 71 | 0.040 |
Why?
| Membranes, Artificial | 2 | 1994 | 15 | 0.040 |
Why?
| Pancreas | 2 | 2001 | 70 | 0.040 |
Why?
| Formazans | 1 | 1998 | 2 | 0.040 |
Why?
| Metabolism, Inborn Errors | 1 | 1998 | 17 | 0.040 |
Why?
| DNA Adducts | 1 | 1999 | 78 | 0.040 |
Why?
| Oxygen Consumption | 2 | 1976 | 183 | 0.040 |
Why?
| Solvents | 2 | 1997 | 29 | 0.040 |
Why?
| Cholagogues and Choleretics | 1 | 1998 | 6 | 0.040 |
Why?
| Receptors, Cholinergic | 1 | 1998 | 14 | 0.040 |
Why?
| Microvilli | 1 | 1998 | 6 | 0.040 |
Why?
| Oxygen | 1 | 2001 | 326 | 0.040 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1998 | 46 | 0.040 |
Why?
| Glutamic Acid | 1 | 1999 | 107 | 0.040 |
Why?
| Reference Values | 2 | 2004 | 310 | 0.040 |
Why?
| Methionine | 1 | 1999 | 135 | 0.040 |
Why?
| HEPES | 1 | 1997 | 3 | 0.040 |
Why?
| Atropine | 3 | 2003 | 30 | 0.040 |
Why?
| Enzyme Activation | 3 | 2004 | 276 | 0.040 |
Why?
| Static Electricity | 1 | 1997 | 21 | 0.040 |
Why?
| Carbachol | 3 | 2002 | 27 | 0.040 |
Why?
| Benzene Derivatives | 1 | 1997 | 6 | 0.040 |
Why?
| DNA Damage | 1 | 1999 | 301 | 0.040 |
Why?
| T-Lymphocyte Subsets | 1 | 1997 | 39 | 0.040 |
Why?
| Caspase 3 | 2 | 2007 | 97 | 0.040 |
Why?
| Protein Denaturation | 1 | 1996 | 15 | 0.040 |
Why?
| Ethacrynic Acid | 1 | 1996 | 3 | 0.040 |
Why?
| Rats, Inbred F344 | 3 | 1992 | 196 | 0.040 |
Why?
| Diuretics | 1 | 1996 | 23 | 0.040 |
Why?
| Uterus | 1 | 1997 | 94 | 0.030 |
Why?
| Adaptation, Physiological | 1 | 1976 | 91 | 0.030 |
Why?
| Cell Survival | 4 | 2007 | 600 | 0.030 |
Why?
| Protein Carbonylation | 1 | 2015 | 4 | 0.030 |
Why?
| Transcription, Genetic | 2 | 2011 | 369 | 0.030 |
Why?
| Rabbits | 5 | 1991 | 370 | 0.030 |
Why?
| Fluorescent Antibody Technique | 2 | 2009 | 108 | 0.030 |
Why?
| Methylation | 3 | 1992 | 122 | 0.030 |
Why?
| Chemokine CXCL2 | 1 | 2014 | 12 | 0.030 |
Why?
| Endothelium, Vascular | 1 | 1996 | 252 | 0.030 |
Why?
| Vanadates | 1 | 1994 | 8 | 0.030 |
Why?
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 20 | 0.030 |
Why?
| Ethylmaleimide | 1 | 1994 | 3 | 0.030 |
Why?
| Microscopy, Fluorescence | 2 | 2007 | 162 | 0.030 |
Why?
| Eye | 1 | 1995 | 31 | 0.030 |
Why?
| Oligodeoxyribonucleotides | 1 | 1994 | 29 | 0.030 |
Why?
| Matrix Metalloproteinases | 1 | 2014 | 48 | 0.030 |
Why?
| Diet, High-Fat | 1 | 2016 | 222 | 0.030 |
Why?
| Alanine Transaminase | 1 | 2014 | 124 | 0.030 |
Why?
| Transcriptome | 1 | 2016 | 315 | 0.030 |
Why?
| Drug Resistance | 3 | 2003 | 63 | 0.030 |
Why?
| Antibodies | 1 | 2014 | 154 | 0.030 |
Why?
| Daunorubicin | 1 | 1994 | 11 | 0.030 |
Why?
| Actins | 1 | 2014 | 118 | 0.030 |
Why?
| Genetic Variation | 3 | 2000 | 213 | 0.030 |
Why?
| Membrane Transport Proteins | 3 | 1999 | 49 | 0.030 |
Why?
| Vinblastine | 1 | 1994 | 23 | 0.030 |
Why?
| Fibrosis | 1 | 2014 | 179 | 0.030 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1994 | 66 | 0.030 |
Why?
| Transforming Growth Factor beta | 1 | 2014 | 144 | 0.030 |
Why?
| Muscles | 2 | 1992 | 103 | 0.030 |
Why?
| Perfusion | 2 | 1990 | 48 | 0.030 |
Why?
| Bilirubin | 1 | 1993 | 40 | 0.030 |
Why?
| Sheep | 1 | 1993 | 89 | 0.030 |
Why?
| Dose-Response Relationship, Immunologic | 2 | 2003 | 13 | 0.030 |
Why?
| Testis | 2 | 2005 | 69 | 0.030 |
Why?
| In Situ Nick-End Labeling | 2 | 2004 | 57 | 0.030 |
Why?
| Leukotrienes | 1 | 1992 | 9 | 0.030 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2014 | 388 | 0.030 |
Why?
| Rats, Sprague-Dawley | 3 | 2002 | 1597 | 0.030 |
Why?
| Methylamines | 2 | 1983 | 17 | 0.030 |
Why?
| HL-60 Cells | 2 | 2003 | 18 | 0.030 |
Why?
| S-Adenosylmethionine | 2 | 1983 | 63 | 0.030 |
Why?
| Molecular Structure | 3 | 2000 | 297 | 0.030 |
Why?
| Affinity Labels | 1 | 1991 | 5 | 0.030 |
Why?
| Uridine Diphosphate Glucuronic Acid | 1 | 1991 | 9 | 0.030 |
Why?
| Mice, 129 Strain | 1 | 2011 | 38 | 0.030 |
Why?
| Chemistry, Physical | 1 | 1991 | 6 | 0.030 |
Why?
| Chemical Phenomena | 1 | 1991 | 17 | 0.020 |
Why?
| Solutions | 1 | 1991 | 25 | 0.020 |
Why?
| Cytokines | 1 | 2014 | 612 | 0.020 |
Why?
| Pseudomonas Infections | 1 | 2011 | 48 | 0.020 |
Why?
| Disease Susceptibility | 1 | 2011 | 89 | 0.020 |
Why?
| Androstenedione | 1 | 1991 | 4 | 0.020 |
Why?
| Clofibrate | 1 | 1991 | 7 | 0.020 |
Why?
| Myocardium | 1 | 1994 | 436 | 0.020 |
Why?
| Steroid Hydroxylases | 1 | 1991 | 18 | 0.020 |
Why?
| Bile Ducts | 1 | 1991 | 45 | 0.020 |
Why?
| Molecular Conformation | 2 | 2004 | 67 | 0.020 |
Why?
| Phenobarbital | 1 | 1991 | 17 | 0.020 |
Why?
| Enzyme Induction | 1 | 1991 | 80 | 0.020 |
Why?
| Sulfurtransferases | 1 | 1990 | 3 | 0.020 |
Why?
| Cytosol | 2 | 2007 | 82 | 0.020 |
Why?
| Drug Resistance, Multiple | 2 | 2002 | 23 | 0.020 |
Why?
| Cholic Acid | 1 | 1990 | 1 | 0.020 |
Why?
| Taurocholic Acid | 1 | 1990 | 5 | 0.020 |
Why?
| Brain | 2 | 2001 | 1328 | 0.020 |
Why?
| Sulfotransferases | 1 | 1990 | 40 | 0.020 |
Why?
| Liver Circulation | 1 | 1990 | 22 | 0.020 |
Why?
| Immunohistochemistry | 2 | 2004 | 973 | 0.020 |
Why?
| Drug Interactions | 2 | 2003 | 206 | 0.020 |
Why?
| Azides | 2 | 2001 | 9 | 0.020 |
Why?
| Photoaffinity Labels | 2 | 2001 | 15 | 0.020 |
Why?
| NADPH Dehydrogenase | 1 | 1989 | 9 | 0.020 |
Why?
| Longitudinal Studies | 1 | 2011 | 688 | 0.020 |
Why?
| Biotinylation | 1 | 2009 | 26 | 0.020 |
Why?
| Glutathione Disulfide | 2 | 2000 | 41 | 0.020 |
Why?
| Gas Chromatography-Mass Spectrometry | 1 | 1989 | 67 | 0.020 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 63 | 0.020 |
Why?
| Cell Line, Tumor | 2 | 2003 | 1403 | 0.020 |
Why?
| Models, Chemical | 2 | 1999 | 66 | 0.020 |
Why?
| Dexamethasone | 1 | 1991 | 430 | 0.020 |
Why?
| Precipitin Tests | 2 | 2002 | 32 | 0.020 |
Why?
| Survival Rate | 1 | 2011 | 894 | 0.020 |
Why?
| Case-Control Studies | 1 | 2011 | 1131 | 0.020 |
Why?
| MAP Kinase Kinase Kinase 5 | 1 | 2007 | 1 | 0.020 |
Why?
| Anthracenes | 1 | 2007 | 9 | 0.020 |
Why?
| Caspase 8 | 1 | 2007 | 12 | 0.020 |
Why?
| Protein Structure, Tertiary | 1 | 2008 | 253 | 0.020 |
Why?
| 3-Hydroxysteroid Dehydrogenases | 1 | 1987 | 3 | 0.020 |
Why?
| Jurkat Cells | 1 | 2007 | 29 | 0.020 |
Why?
| Organ Specificity | 2 | 2001 | 108 | 0.020 |
Why?
| Co-Repressor Proteins | 1 | 2007 | 19 | 0.020 |
Why?
| Immunoprecipitation | 1 | 2007 | 59 | 0.020 |
Why?
| HSP70 Heat-Shock Proteins | 1 | 2007 | 62 | 0.020 |
Why?
| Molecular Chaperones | 1 | 2007 | 64 | 0.020 |
Why?
| RNA, Small Interfering | 1 | 2007 | 215 | 0.020 |
Why?
| Protein Transport | 1 | 2007 | 180 | 0.020 |
Why?
| Isoelectric Point | 2 | 1998 | 4 | 0.020 |
Why?
| Cell Transformation, Viral | 1 | 2006 | 25 | 0.020 |
Why?
| MAP Kinase Kinase 4 | 1 | 2006 | 29 | 0.020 |
Why?
| Blood Platelets | 1 | 2009 | 245 | 0.020 |
Why?
| Lens, Crystalline | 1 | 2006 | 20 | 0.020 |
Why?
| Cell Separation | 2 | 2001 | 89 | 0.020 |
Why?
| Caspases | 1 | 2006 | 104 | 0.020 |
Why?
| Chloramphenicol O-Acetyltransferase | 1 | 2005 | 8 | 0.020 |
Why?
| Paraquat | 1 | 2005 | 5 | 0.020 |
Why?
| Fatty Acid-Binding Proteins | 1 | 2005 | 19 | 0.020 |
Why?
| Prospective Studies | 1 | 2011 | 2364 | 0.020 |
Why?
| Cytoskeletal Proteins | 1 | 2005 | 49 | 0.020 |
Why?
| NF-E2-Related Factor 2 | 1 | 2005 | 41 | 0.020 |
Why?
| Superoxide Dismutase | 1 | 2005 | 113 | 0.020 |
Why?
| Pregnancy | 3 | 1998 | 2607 | 0.020 |
Why?
| Insulin-Like Growth Factor I | 1 | 2005 | 137 | 0.020 |
Why?
| Spleen | 1 | 2005 | 172 | 0.020 |
Why?
| DNA-Binding Proteins | 1 | 2007 | 427 | 0.020 |
Why?
| Hydrophobic and Hydrophilic Interactions | 1 | 2004 | 36 | 0.020 |
Why?
| Microinjections | 1 | 2004 | 29 | 0.010 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 1 | 2004 | 62 | 0.010 |
Why?
| Cattle | 2 | 1996 | 210 | 0.010 |
Why?
| Glutamate-Ammonia Ligase | 1 | 1983 | 9 | 0.010 |
Why?
| Tyrphostins | 1 | 2003 | 9 | 0.010 |
Why?
| Mice, Transgenic | 1 | 2005 | 555 | 0.010 |
Why?
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2003 | 7 | 0.010 |
Why?
| Kidney | 1 | 1988 | 665 | 0.010 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 50 | 0.010 |
Why?
| Calcium Radioisotopes | 1 | 1983 | 7 | 0.010 |
Why?
| Quinazolines | 1 | 2003 | 33 | 0.010 |
Why?
| Xanthine Oxidase | 1 | 2003 | 14 | 0.010 |
Why?
| Drug Design | 1 | 2004 | 120 | 0.010 |
Why?
| GTP Phosphohydrolases | 1 | 2003 | 31 | 0.010 |
Why?
| S-Adenosylhomocysteine | 1 | 1983 | 47 | 0.010 |
Why?
| Ultraviolet Rays | 1 | 2003 | 51 | 0.010 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 142 | 0.010 |
Why?
| Flavonoids | 1 | 2003 | 58 | 0.010 |
Why?
| Transcriptional Activation | 1 | 2003 | 121 | 0.010 |
Why?
| Trypsin | 1 | 2003 | 12 | 0.010 |
Why?
| U937 Cells | 1 | 2003 | 14 | 0.010 |
Why?
| Sex Factors | 1 | 2005 | 691 | 0.010 |
Why?
| Inhibitory Concentration 50 | 1 | 2003 | 76 | 0.010 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 1 | 2003 | 47 | 0.010 |
Why?
| Cross Reactions | 1 | 2003 | 42 | 0.010 |
Why?
| Intracellular Membranes | 1 | 1983 | 22 | 0.010 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2003 | 184 | 0.010 |
Why?
| Computational Biology | 1 | 2004 | 214 | 0.010 |
Why?
| Cell Cycle | 1 | 2004 | 231 | 0.010 |
Why?
| Mice, Inbred A | 1 | 2002 | 15 | 0.010 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 141 | 0.010 |
Why?
| Cholinesterases | 1 | 2002 | 2 | 0.010 |
Why?
| Catalytic Domain | 1 | 2002 | 57 | 0.010 |
Why?
| Selenium | 1 | 2002 | 8 | 0.010 |
Why?
| Mass Spectrometry | 3 | 1992 | 306 | 0.010 |
Why?
| Osmolar Concentration | 2 | 1999 | 62 | 0.010 |
Why?
| Tritium | 1 | 2002 | 47 | 0.010 |
Why?
| Adenosine Monophosphate | 1 | 2002 | 15 | 0.010 |
Why?
| Glycine | 1 | 2002 | 75 | 0.010 |
Why?
| Endothelial Cells | 1 | 2004 | 269 | 0.010 |
Why?
| Filtration | 1 | 2002 | 24 | 0.010 |
Why?
| Hydrolysis | 2 | 1992 | 63 | 0.010 |
Why?
| Intestine, Small | 1 | 2002 | 109 | 0.010 |
Why?
| Sensitivity and Specificity | 1 | 2004 | 861 | 0.010 |
Why?
| Blotting, Northern | 1 | 2001 | 109 | 0.010 |
Why?
| Isoelectric Focusing | 1 | 2001 | 8 | 0.010 |
Why?
| Heat-Shock Response | 1 | 2001 | 28 | 0.010 |
Why?
| Cations | 1 | 1981 | 10 | 0.010 |
Why?
| Phosphorus Radioisotopes | 1 | 2001 | 8 | 0.010 |
Why?
| Antibody Specificity | 1 | 2001 | 36 | 0.010 |
Why?
| Culture Media | 1 | 2001 | 94 | 0.010 |
Why?
| Transcription Factor AP-1 | 1 | 2001 | 63 | 0.010 |
Why?
| Haptens | 1 | 2001 | 10 | 0.010 |
Why?
| DNA Fragmentation | 1 | 2001 | 55 | 0.010 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2003 | 225 | 0.010 |
Why?
| Sulfuric Acids | 2 | 1991 | 8 | 0.010 |
Why?
| Amino Acid Motifs | 1 | 2001 | 56 | 0.010 |
Why?
| Phenylmethylsulfonyl Fluoride | 1 | 2001 | 1 | 0.010 |
Why?
| ral GTP-Binding Proteins | 1 | 2001 | 3 | 0.010 |
Why?
| Brain Chemistry | 1 | 2001 | 70 | 0.010 |
Why?
| Metals, Rare Earth | 1 | 1980 | 1 | 0.010 |
Why?
| Lanthanum | 1 | 1980 | 4 | 0.010 |
Why?
| Ruthenium Red | 1 | 1980 | 5 | 0.010 |
Why?
| Isomerism | 1 | 2000 | 22 | 0.010 |
Why?
| Alkylating Agents | 1 | 2000 | 23 | 0.010 |
Why?
| Intracellular Fluid | 1 | 2000 | 12 | 0.010 |
Why?
| Acrolein | 1 | 2000 | 3 | 0.010 |
Why?
| Gene Expression Profiling | 1 | 2005 | 1032 | 0.010 |
Why?
| Cell Adhesion | 1 | 2000 | 158 | 0.010 |
Why?
| Erythropoiesis | 1 | 1999 | 16 | 0.010 |
Why?
| Macromolecular Substances | 1 | 1999 | 35 | 0.010 |
Why?
| Dimerization | 1 | 1999 | 52 | 0.010 |
Why?
| Cross-Linking Reagents | 1 | 1999 | 44 | 0.010 |
Why?
| Leukotriene C4 | 1 | 1999 | 1 | 0.010 |
Why?
| Glucosides | 1 | 1979 | 16 | 0.010 |
Why?
| Glycosides | 1 | 1979 | 17 | 0.010 |
Why?
| Antibodies, Monoclonal | 1 | 2003 | 459 | 0.010 |
Why?
| Laryngeal Neoplasms | 1 | 1999 | 42 | 0.010 |
Why?
| Baculoviridae | 1 | 1998 | 5 | 0.010 |
Why?
| Parenteral Nutrition, Total | 1 | 1998 | 31 | 0.010 |
Why?
| False Positive Reactions | 1 | 1998 | 63 | 0.010 |
Why?
| Anilino Naphthalenesulfonates | 1 | 1978 | 5 | 0.010 |
Why?
| Gene Transfer Techniques | 1 | 1998 | 37 | 0.010 |
Why?
| Flow Cytometry | 1 | 2001 | 476 | 0.010 |
Why?
| Pepsinogens | 1 | 1998 | 1 | 0.010 |
Why?
| Air Pollutants | 1 | 1999 | 60 | 0.010 |
Why?
| Sincalide | 1 | 1998 | 2 | 0.010 |
Why?
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1998 | 3 | 0.010 |
Why?
| Parasympatholytics | 1 | 1998 | 11 | 0.010 |
Why?
| Cholecystokinin | 1 | 1998 | 20 | 0.010 |
Why?
| Fluorescence | 1 | 1978 | 41 | 0.010 |
Why?
| Osmotic Pressure | 1 | 1998 | 10 | 0.010 |
Why?
| Fluoresceins | 1 | 1998 | 11 | 0.010 |
Why?
| Cell Count | 1 | 1998 | 147 | 0.010 |
Why?
| Spectrometry, Fluorescence | 1 | 1998 | 45 | 0.010 |
Why?
| Caco-2 Cells | 1 | 1998 | 48 | 0.010 |
Why?
| Amino Acids | 1 | 2000 | 360 | 0.010 |
Why?
| Fluorescent Dyes | 1 | 1998 | 102 | 0.010 |
Why?
| Benzo(a)pyrene | 1 | 1997 | 12 | 0.010 |
Why?
| In Situ Hybridization | 1 | 1997 | 65 | 0.010 |
Why?
| Temperature | 1 | 1998 | 168 | 0.010 |
Why?
| Cell Differentiation | 1 | 1999 | 651 | 0.010 |
Why?
| Microbodies | 1 | 1976 | 3 | 0.010 |
Why?
| Bone Marrow Cells | 1 | 1997 | 191 | 0.010 |
Why?
| Drug Screening Assays, Antitumor | 1 | 1996 | 136 | 0.010 |
Why?
| Organoids | 1 | 1976 | 39 | 0.010 |
Why?
| Carcinoma, Squamous Cell | 1 | 1999 | 318 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 1999 | 510 | 0.010 |
Why?
| Heme | 1 | 1975 | 21 | 0.010 |
Why?
| Sepsis | 1 | 1998 | 220 | 0.010 |
Why?
| Algorithms | 1 | 1999 | 615 | 0.010 |
Why?
| Consensus Sequence | 1 | 1994 | 24 | 0.010 |
Why?
| Adult | 3 | 2001 | 13236 | 0.010 |
Why?
| Pregnancy Complications | 1 | 1998 | 382 | 0.010 |
Why?
| Sequence Alignment | 1 | 1994 | 121 | 0.010 |
Why?
| Chickens | 1 | 1994 | 107 | 0.010 |
Why?
| Placenta | 1 | 1994 | 132 | 0.010 |
Why?
| Metals | 1 | 1992 | 34 | 0.010 |
Why?
| Esterification | 1 | 1992 | 6 | 0.010 |
Why?
| Anti-Bacterial Agents | 1 | 1978 | 744 | 0.010 |
Why?
| Acetylation | 1 | 1992 | 97 | 0.010 |
Why?
| Uridine Diphosphate Glucose Dehydrogenase | 1 | 1991 | 1 | 0.010 |
Why?
| Photochemistry | 1 | 1991 | 15 | 0.010 |
Why?
| Ligation | 1 | 1991 | 59 | 0.010 |
Why?
| Infant, Newborn | 1 | 1998 | 2772 | 0.010 |
Why?
| Sulfobromophthalein | 1 | 1989 | 3 | 0.010 |
Why?
| Androstanols | 1 | 1989 | 5 | 0.010 |
Why?
| Neoplasms | 1 | 2000 | 1235 | 0.010 |
Why?
| Calcimycin | 1 | 1989 | 6 | 0.010 |
Why?
| Ionomycin | 1 | 1988 | 4 | 0.010 |
Why?
| Ethers | 1 | 1988 | 8 | 0.010 |
Why?
| Cell Membrane Permeability | 1 | 1988 | 28 | 0.000 |
Why?
| L-Lactate Dehydrogenase | 1 | 1988 | 65 | 0.000 |
Why?
| Ca(2+) Mg(2+)-ATPase | 1 | 1988 | 2 | 0.000 |
Why?
| 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific) | 1 | 1987 | 1 | 0.000 |
Why?
| Swine | 1 | 1988 | 393 | 0.000 |
Why?
| Scintillation Counting | 1 | 1986 | 1 | 0.000 |
Why?
| Spectrum Analysis | 1 | 1986 | 70 | 0.000 |
Why?
| Chromatography, Gas | 1 | 1986 | 14 | 0.000 |
Why?
| Infusions, Intravenous | 1 | 1986 | 206 | 0.000 |
Why?
| Aged | 2 | 1990 | 9310 | 0.000 |
Why?
| Methionine Sulfoximine | 1 | 1983 | 7 | 0.000 |
Why?
| Chloroform | 1 | 1980 | 5 | 0.000 |
Why?
| Methanol | 1 | 1980 | 10 | 0.000 |
Why?
| Chromatography, Gel | 1 | 1980 | 39 | 0.000 |
Why?
| Diacylglycerol Cholinephosphotransferase | 1 | 1980 | 1 | 0.000 |
Why?
| Ethanolaminephosphotransferase | 1 | 1980 | 1 | 0.000 |
Why?
| Centrifugation, Density Gradient | 1 | 1980 | 17 | 0.000 |
Why?
| Muscle Development | 1 | 1980 | 24 | 0.000 |
Why?
| Adolescent | 1 | 1990 | 6356 | 0.000 |
Why?
| Potassium Chloride | 1 | 1979 | 20 | 0.000 |
Why?
| Child, Preschool | 1 | 1987 | 3871 | 0.000 |
Why?
| Child | 1 | 1990 | 6847 | 0.000 |
Why?
| Ultracentrifugation | 1 | 1976 | 9 | 0.000 |
Why?
| Spheroplasts | 1 | 1976 | 4 | 0.000 |
Why?
| Middle Aged | 1 | 1990 | 12069 | 0.000 |
Why?
| Fungal Proteins | 1 | 1976 | 118 | 0.000 |
Why?
|
|
Zimniak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|